214 related articles for article (PubMed ID: 32971892)
1. Design, Synthesis, In Vitro and In Silico Studies of New Thiazolylhydrazine-Piperazine Derivatives as Selective MAO-A Inhibitors.
Sağlık BN; Cebeci O; Acar Çevik U; Osmaniye D; Levent S; Kaya Çavuşoğlu B; Ilgın S; Özkay Y; Kaplancıklı ZA
Molecules; 2020 Sep; 25(18):. PubMed ID: 32971892
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of new hydrazone derivatives and evaluation of their monoamine oxidase inhibitory activity.
Tok F; Sağlık BN; Özkay Y; Ilgın S; Kaplancıklı ZA; Koçyiğit-Kaymakçıoğlu B
Bioorg Chem; 2021 Sep; 114():105038. PubMed ID: 34102520
[TBL] [Abstract][Full Text] [Related]
3. Design and Synthesis of New Benzothiazole Compounds as Selective hMAO-B Inhibitors.
Ilgın S; Osmaniye D; Levent S; Sağlık BN; Acar Çevik U; Çavuşoğlu BK; Özkay Y; Kaplancıklı ZA
Molecules; 2017 Dec; 22(12):. PubMed ID: 29232838
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, monoamine oxidase inhibition activity and molecular docking studies of novel 4-hydroxy-N'-[benzylidene or 1-phenylethylidene]-2-H/methyl/benzyl-1,2-benzothiazine-3-carbohydrazide 1,1-dioxides.
Saddique FA; Zaib S; Jalil S; Aslam S; Ahmad M; Sultan S; Naz H; Iqbal M; Iqbal J
Eur J Med Chem; 2018 Jan; 143():1373-1386. PubMed ID: 29126721
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, in vitro, and in silico studies of 1,2,4-triazole-piperazine hybrid derivatives as potential MAO inhibitors.
Uslu H; Osmaniye D; Sağlik BN; Levent S; Özkay Y; Benkli K; Kaplancikli ZA
Bioorg Chem; 2021 Dec; 117():105430. PubMed ID: 34678603
[TBL] [Abstract][Full Text] [Related]
6. Design, Synthesis, and Biological Evaluation of Pyridazinones Containing the (2-Fluorophenyl) Piperazine Moiety as Selective MAO-B Inhibitors.
Çeçen M; Oh JM; Özdemir Z; Büyüktuncel SE; Uysal M; Abdelgawad MA; Musa A; Gambacorta N; Nicolotti O; Mathew B; Kim H
Molecules; 2020 Nov; 25(22):. PubMed ID: 33212876
[TBL] [Abstract][Full Text] [Related]
7. Biphenylpiperazine Based MAO Inhibitors: Synthesis, Biological Evaluation, Reversibility and Molecular Modeling Studies.
El-Halaby LO; El-Husseiny WM; El-Messery SM; Goda FE
Bioorg Chem; 2021 Oct; 115():105216. PubMed ID: 34352710
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, in vitro and in silico evaluation of new pyrrole derivatives as monoamine oxidase inhibitors.
Altintop MD; Sever B; Osmaniye D; Sağlık BN; Özdemir A
Arch Pharm (Weinheim); 2018 Jul; 351(7):e1800082. PubMed ID: 29963739
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in silico evaluation of new thiazole compounds as monoamine oxidase inhibitors.
Sağlık BN; Kaya Çavuşoğlu B; Osmaniye D; Levent S; Acar Çevik U; Ilgın S; Özkay Y; Kaplancıklı ZA; Öztürk Y
Bioorg Chem; 2019 Apr; 85():97-108. PubMed ID: 30605888
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and biological assessment of new thiazolylhydrazine derivatives as selective and reversible hMAO-A inhibitors.
Can NÖ; Osmaniye D; Levent S; Sağlık BN; Korkut B; Atlı Ö; Özkay Y; Kaplancıklı ZA
Eur J Med Chem; 2018 Jan; 144():68-81. PubMed ID: 29248751
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, monoamine oxidase inhibition and docking studies of new dithiocarbamate derivatives bearing benzylamine moiety.
Kaya Çavuşoğlu B; Sağlık BN; Özkay Y; İnci B; Kaplancıklı ZA
Bioorg Chem; 2018 Feb; 76():177-187. PubMed ID: 29175589
[TBL] [Abstract][Full Text] [Related]
12. Sulfonyl hydrazones derived from 3-formylchromone as non-selective inhibitors of MAO-A and MAO-B: Synthesis, molecular modelling and in-silico ADME evaluation.
Abid SMA; Younus HA; Al-Rashida M; Arshad Z; Maryum T; Gilani MA; Alharthi AI; Iqbal J
Bioorg Chem; 2017 Dec; 75():291-302. PubMed ID: 29065322
[TBL] [Abstract][Full Text] [Related]
13. 2-acetylphenol analogs as potent reversible monoamine oxidase inhibitors.
Legoabe LJ; Petzer A; Petzer JP
Drug Des Devel Ther; 2015; 9():3635-44. PubMed ID: 26203229
[TBL] [Abstract][Full Text] [Related]
14. Combined 3D-QSAR and docking analysis for the design and synthesis of chalcones as potent and selective monoamine oxidase B inhibitors.
Mellado M; González C; Mella J; Aguilar LF; Viña D; Uriarte E; Cuellar M; Matos MJ
Bioorg Chem; 2021 Mar; 108():104689. PubMed ID: 33571810
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and Biological Evaluation of New Thiosemicarbazone Derivative Schiff Bases as Monoamine Oxidase Inhibitory Agents.
Çavuşoğlu BK; Sağlık BN; Osmaniye D; Levent S; Acar Çevik U; Karaduman AB; Özkay Y; Kaplancıklı ZA
Molecules; 2017 Dec; 23(1):. PubMed ID: 29283399
[TBL] [Abstract][Full Text] [Related]
16. Novel 1-(2-pyrimidin-2-yl)piperazine derivatives as selective monoamine oxidase (MAO)-A inhibitors.
Kaya B; Yurttaş L; Sağlik BN; Levent S; Özkay Y; Kaplancikli ZA
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):193-202. PubMed ID: 28097890
[TBL] [Abstract][Full Text] [Related]
17. New 2H-chromene-3-carboxamide derivatives: design, synthesis and use as inhibitors of hMAO.
Pan ZX; He X; Chen YY; Tang WJ; Shi JB; Tang YL; Song BA; Li J; Liu XH
Eur J Med Chem; 2014 Jun; 80():278-84. PubMed ID: 24793878
[TBL] [Abstract][Full Text] [Related]
18. Exploration of a Library of 3,4-(Methylenedioxy)aniline-Derived Semicarbazones as Dual Inhibitors of Monoamine Oxidase and Acetylcholinesterase: Design, Synthesis, and Evaluation.
Tripathi RK; Rai GK; Ayyannan SR
ChemMedChem; 2016 Jun; 11(11):1145-60. PubMed ID: 27135466
[TBL] [Abstract][Full Text] [Related]
19. Exploring new selective 3-benzylquinoxaline-based MAO-A inhibitors: design, synthesis, biological evaluation and docking studies.
Khattab SN; Abdel Moneim SA; Bekhit AA; El Massry AM; Hassan SY; El-Faham A; Ali Ahmed HE; Amer A
Eur J Med Chem; 2015 Mar; 93():308-20. PubMed ID: 25707011
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and biological assessment of new selective COX-2 inhibitors including methyl sulfonyl moiety.
Sağlık BN; Osmaniye D; Levent S; Çevik UA; Çavuşoğlu BK; Özkay Y; Kaplancıklı ZA
Eur J Med Chem; 2021 Jan; 209():112918. PubMed ID: 33071054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
